Skip to main content
Premium Trial:

Request an Annual Quote

Waters, Advion Finish Evaluating Integration of Synapt MS With NanoMate Infusion Tech

NEW YORK (GenomeWeb News) — Waters and Advion Biosciences have completed the evaluation phase of a product-integration effort and have kicked off a co-marketing campaign this week at the LC-MS Montreux Symposium in Switzerland, Waters said.
 
The companies are integrating Advion’s TriVersa NanoMate infusion technology with Waters’ Synapt high definition mass spectrometer into a platform that Waters said will help researchers maximize the information they can pull from large quantities of samples.
 
An Advion spokesperson said the products will be interoperable in three to six months.
 
Waters’ Synapt can probe the size and shape of ions, while Advion’s NanoMate makes it easier to maintain the “native conformation of protein or peptide ions into the gas phase,” which the company said also increases reproducibility.
 
Waters said the integrated product will be used to “analyze monoclonal antibodies, multi-protein and protein-ligand complexes, top down proteomics and metabolite identification."

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.